<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 12.4: The Gut-Skin Axis: Dermatological Health & Dysbiosis</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .content-list {
            font-size: 17px;
            margin: 20px 0;
            padding-left: 24px;
        }

        .content-list li {
            margin-bottom: 14px;
            line-height: 1.7;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            font-weight: 700;
            color: #059669;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #10B981, #059669);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #f1f8f1;
            color: #059669;
            text-align: left;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #10B981;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #2e7d32;
            margin-top: 14px;
            padding: 14px;
            background: #f0f8f0;
            border-radius: 8px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            color: #888;
        }

        @media (max-width: 768px) {
            .lesson-container { padding: 20px 15px; }
            .toc-list { grid-template-columns: 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 12: Advanced Systemic Interconnections</p>
            <h1 class="lesson-title">Lesson 12.4: The Gut-Skin Axis: Dermatological Health & Dysbiosis</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#neurogenic"><span class="section-num">1</span>Neurogenic Inflammation & Substance P</a></li>
                <li><a href="#signatures"><span class="section-num">2</span>Microbiome Signatures of Skin Disease</a></li>
                <li><a href="#scfas"><span class="section-num">3</span>SCFAs: Systemic Skin Mediators</a></li>
                <li><a href="#endotoxemia"><span class="section-num">4</span>Metabolic Endotoxemia & The Skin Barrier</a></li>
                <li><a href="#probiotics"><span class="section-num">5</span>Oral vs. Topical Probiotics</a></li>
                <li><a href="#clinical"><span class="section-num">6</span>Clinical Application & Case Studies</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the bidirectional communication pathways between the gut microbiome and the integumentary system.</li>
                <li>Evaluate the role of <span class="highlight">Substance P</span> and pro-inflammatory cytokines in triggering dermatological flares.</li>
                <li>Identify specific microbial dysbiosis patterns associated with Acne Vulgaris, Rosacea, and Psoriasis.</li>
                <li>Explain how Short-Chain Fatty Acids (SCFAs) act as systemic anti-inflammatory agents for skin barrier repair.</li>
                <li>Design a gut-centric protocol for chronic skin conditions based on the latest clinical evidence.</li>
            </ul>
        </div>

        <h2 id="neurogenic">1. Neurogenic Inflammation & Substance P</h2>
        <p>The gut and skin are both highly innervated, richly vascularized organs that serve as our primary interfaces with the external environment. This connection is mediated by the <span class="highlight">Gut-Skin Axis</span>, a complex communication network involving immune, endocrine, and neural signaling. A central player in this axis is <strong>Substance P</strong>, a neuropeptide released from non-myelinated sensory nerve fibers.</p>
        
        <p>When the gut experiences dysbiosis or increased permeability, it triggers a systemic inflammatory response. This stress signal stimulates the release of Substance P, which travels through the circulation to the skin. In the dermis, Substance P promotes:</p>
        <ul class="content-list">
            <li><strong>Mast Cell Degranulation:</strong> Releasing histamine and heparin, leading to redness and itching.</li>
            <li><strong>Vasodilation:</strong> Increasing blood flow and promoting the "flush" often seen in Rosacea.</li>
            <li><strong>Sebum Production:</strong> Stimulating sebaceous glands, which can exacerbate Acne Vulgaris.</li>
        </ul>

        <div class="alert-box info">
            <p class="alert-label">Scientific Insight</p>
            <p>A landmark study demonstrated that intestinal bacteria can directly influence skin behavior by modulating Substance P. In murine models, the administration of <i>Lactobacillus reuteri</i> was found to decrease Substance P levels in the skin, resulting in increased dermal thickness and improved follicular growthâ€”a phenomenon termed the "Glow of Health."</p>
        </div>

        <h2 id="signatures">2. Microbiome Signatures of Skin Disease</h2>
        <p>Research has increasingly identified distinct "microbial signatures" in the gut that correlate with specific dermatological conditions. While the skin has its own microbiome (the cutaneous microbiome), the <strong>gut microbiome</strong> acts as the systemic thermostat for skin health.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Condition</th>
                        <th>Gut Microbiome Signature</th>
                        <th>Systemic Mechanism</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Acne Vulgaris</strong></td>
                        <td>Reduced diversity; Lower <i>Bifidobacterium</i>; Higher <i>Bacteroides</i>.</td>
                        <td>Increased mTORC1 signaling and sebum lipogenesis via gut-derived insulinogenic pathways.</td>
                    </tr>
                    <tr>
                        <td><strong>Rosacea</strong></td>
                        <td>High correlation with <strong>SIBO</strong> (Small Intestinal Bacterial Overgrowth).</td>
                        <td>Increased Substance P and systemic pro-inflammatory cytokines (IL-1Î², TNF-Î±).</td>
                    </tr>
                    <tr>
                        <td><strong>Psoriasis</strong></td>
                        <td>Decreased <i>Akkermansia muciniphila</i>; Elevated Firmicutes/Bacteroidetes ratio.</td>
                        <td>Translocation of bacterial DNA into systemic circulation triggering Th17 immune responses.</td>
                    </tr>
                    <tr>
                        <td><strong>Atopic Dermatitis</strong></td>
                        <td>Low microbial diversity in early life; Low <i>Faecalibacterium prausnitzii</i>.</td>
                        <td>Reduced regulatory T-cell (Treg) induction, leading to hyper-IgE and allergic skin response.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>In patients with Rosacea, the prevalence of <span class="highlight">SIBO</span> is significantly higher than in healthy controls. A 2021 meta-analysis found that Rosacea patients were <span class="stat-highlight">13.7 times more likely</span> to test positive for SIBO. Furthermore, the eradication of SIBO often leads to the complete remission of skin lesions, reinforcing the gut-skin causality.</p>

        <h2 id="scfas">3. SCFAs: Systemic Skin Mediators</h2>
        <p>As covered in previous modules, Short-Chain Fatty Acids (SCFAs)â€”primarily acetate, propionate, and butyrateâ€”are the fermentation products of dietary fiber. While their primary role is local (feeding colonocytes), their systemic effects are profound for the skin.</p>
        
        <p>SCFAs enter the systemic circulation and reach the skin, where they act as potent anti-inflammatory agents by inhibiting <strong>Histone Deacetylases (HDACs)</strong>. This inhibition promotes the differentiation of regulatory T-cells (Tregs) in the skin, which dampens excessive immune responses. Furthermore, butyrate has been shown to:</p>
        <ul class="content-list">
            <li><strong>Enhance Skin Barrier Function:</strong> By upregulating the expression of tight junction proteins in the epidermis.</li>
            <li><strong>Promote Antimicrobial Peptide (AMP) Production:</strong> Helping the skin defend against pathogens like <i>Staphylococcus aureus</i>.</li>
            <li><strong>Regulate Keratinocyte Proliferation:</strong> Preventing the hyper-keratosis seen in conditions like Psoriasis.</li>
        </ul>

        <h2 id="endotoxemia">4. Metabolic Endotoxemia & The Skin Barrier</h2>
        <p>The concept of "leaky gut" (increased intestinal permeability) is critical to understanding chronic skin inflammation. When the intestinal barrier is compromised, <strong>Lipopolysaccharides (LPS)</strong>â€”endotoxins from the cell walls of Gram-negative bacteriaâ€”leak into the bloodstream. This is known as <span class="highlight">Metabolic Endotoxemia</span>.</p>

        <p>LPS binds to Toll-Like Receptor 4 (TLR4) on skin cells, initiating a cascade of pro-inflammatory cytokines. This systemic "fire" manifests on the skin as inflammation, delayed wound healing, and impaired barrier function. A <span class="stat-highlight">2022 study (n=142)</span> found that patients with chronic Psoriasis had significantly higher serum LPS levels compared to controls, and these levels correlated directly with the severity of the Psoriasis Area and Severity Index (PASI) score.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Resolving Treatment-Resistant Rosacea</p>
                    <p style="color: rgba(255,255,255,0.8); margin: 0; font-size: 13px;">Client: Sarah, 34 | Symptoms: Persistent facial flushing and papules</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah (34)</h4>
                        <p>History of IBS-D and moderate-to-severe Rosacea for 5 years. Unresponsive to topical metronidazole.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Sarah underwent a hydrogen/methane breath test, which confirmed SIBO (Hydrogen-dominant). Using "The Method" framework, her protocol focused on:</p>
                <ul>
                    <li><strong>SIBO Eradication:</strong> Targeted herbal antimicrobials (Berberine and Neem).</li>
                    <li><strong>Barrier Support:</strong> High-dose Glutamine and Zinc Carnosine to address intestinal permeability.</li>
                    <li><strong>Microbiome Modulation:</strong> Post-SIBO introduction of <i>Bifidobacterium infantis</i>.</li>
                </ul>
                <p><strong>Outcome:</strong> After 12 weeks, Sarah's SIBO re-test was negative. Concurrently, her Rosacea symptoms improved by <span class="stat-highlight">85%</span>, with a complete cessation of facial flushing. This case illustrates how skin manifestations are often the "smoke" for the "fire" occurring in the small intestine.</p>
            </div>
        </div>

        <h2 id="probiotics">5. Oral vs. Topical Probiotics</h2>
        <p>As a Gut Health Coach, you must distinguish between systemic and local microbiome modulation. While topical probiotics are becoming popular in skincare, oral probiotics remain the gold standard for systemic immune re-education.</p>

        <div class="comparison-grid">
            <div class="comparison-card conventional">
                <p class="card-label">Topical Probiotics</p>
                <p class="card-text">Directly modulate the cutaneous microbiome. Effective for competitive inhibition of pathogens (e.g., <i>S. aureus</i> in eczema) and restoring skin pH. Limited systemic impact.</p>
            </div>
            <div class="comparison-card functional">
                <p class="card-label">Oral Probiotics</p>
                <p class="card-text">Modulate the GALT (Gut-Associated Lymphoid Tissue). Influence systemic cytokine profiles and Substance P levels. Essential for addressing the root cause of inflammatory skin disease.</p>
            </div>
        </div>

        <p>Research suggests that specific strains, such as <i>Lactobacillus rhamnosus GG</i> and <i>Bifidobacterium lactis</i>, are particularly effective for Atopic Dermatitis, while <i>Lactobacillus paracasei</i> has been shown to reduce skin sensitivity and improve barrier function by modulating the neuro-immune system.</p>

        <h2 id="clinical">6. Clinical Application & Case Studies</h2>
        <p>When working with clients who have skin issues, the Gut Health Coach must look beyond the surface. The "Method" approach requires an investigation into digestion, motility, and barrier integrity as the primary drivers of dermatological health.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Psoriasis and the Mycobiome</p>
                    <p style="color: rgba(255,255,255,0.8); margin: 0; font-size: 13px;">Client: James, 52 | Symptoms: Scaly plaques on elbows and knees</p>
                </div>
            </div>
            <div class="case-study-content">
                <p>James presented with chronic Psoriasis and frequent bloating. Stool analysis revealed a significant overgrowth of <i>Candida albicans</i> (fungal dysbiosis) and low secretory IgA (sIgA).</p>
                <p><strong>The Strategy:</strong> Addressing the gut-skin connection through fungal modulation:</p>
                <ul>
                    <li><strong>Antifungal Support:</strong> Caprylic acid and Oregano oil to reduce fungal burden.</li>
                    <li><strong>Immune Priming:</strong> <i>Saccharomyces boulardii</i> to increase sIgA and compete with Candida.</li>
                    <li><strong>Dietary Shift:</strong> Reduction of refined carbohydrates (Candida fuel) and increase in polyphenols (skin protection).</li>
                </ul>
                <p><strong>Outcome:</strong> Within 4 months, James reported a <span class="stat-highlight">60% reduction</span> in plaque coverage and significantly improved skin hydration. This highlights the role of the <strong>Mycobiome</strong> (fungal community) in the gut-skin axis.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the Gut-Skin Axis mechanics.</p>
            
            <div class="question-item">
                <p class="question-text">1. How does Substance P bridge the gap between gut distress and skin flushing?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Gut dysbiosis triggers systemic inflammation, which stimulates the release of the neuropeptide Substance P. Substance P travels via the blood to the skin, where it causes mast cell degranulation and vasodilation, resulting in redness and flushing.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is the primary role of SCFAs in skin barrier health?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">SCFAs (like butyrate) inhibit HDACs, which promotes the differentiation of regulatory T-cells (Tregs) in the skin. They also upregulate tight junction proteins in the epidermis, strengthening the physical skin barrier.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The skin is a mirror of the gut; chronic dermatological issues are often symptoms of systemic dysbiosis.</li>
                <li><strong>Substance P</strong> is a critical mediator of neurogenic inflammation in the gut-skin axis.</li>
                <li><strong>SIBO</strong> has a high clinical correlation with Rosacea; eradication of the overgrowth often resolves the skin condition.</li>
                <li><strong>Metabolic Endotoxemia</strong> (LPS translocation) is a primary driver of systemic inflammation that worsens Psoriasis and Acne.</li>
                <li>Oral probiotics modulate the immune system systemically, while topical probiotics provide localized barrier support.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <p>Salem et al. (2018). "The Gut Microbiome as a Major Regulator of the Gut-Skin Axis." <i>Frontiers in Microbiology</i>.</p>
            <p>Vaughn et al. (2017). "The effects of probiotics on dermatological diseases: as systemic review." <i>Gut Microbes</i>.</p>
            <p>Parodi et al. (2021). "Small Intestinal Bacterial Overgrowth in Rosacea: A Clinical Review." <i>Journal of the American Academy of Dermatology</i>.</p>
            <p>Levkovich et al. (2013). "Probiotic Bacteria Induce a â€˜Glow of Healthâ€™." <i>PLoS ONE</i>.</p>
            <p>O'Neill et al. (2016). "The Gut-Skin Axis in Health and Disease: A Paradigm with Therapeutic Implications." <i>BioEssays</i>.</p>
            <p>Sikora et al. (2022). "Metabolic Endotoxemia and Psoriasis: The Role of the Intestinal Barrier." <i>International Journal of Molecular Sciences</i>.</p>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Gut Health & Microbiome Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>